HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cao Lv Selected Research

bcr-abl Fusion Proteins

1/2016Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cao Lv Research Topics

Disease

1Blast Crisis (Blast Phase)
01/2016
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2016

Drug/Important Bio-Agent (IBA)

1Dasatinib (BMS 354825)FDA Link
01/2016
1AnthelminticsIBA
01/2016
1NiclosamideFDA Link
01/2016
1bcr-abl Fusion ProteinsIBA
01/2016
1Eukaryotic Initiation Factor-4EIBA
01/2016